• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康与疾病:一项基于问卷调查的研究,调查瑞典诺威克纳维亚猎犬的免疫介导性疾病和肿瘤

In sickness and health - a questionnaire based study regarding immune mediated diseases and neoplasia in Swedish Nova Scotia Duck Tolling Retrievers.

机构信息

Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.

出版信息

Acta Vet Scand. 2024 Aug 15;66(1):39. doi: 10.1186/s13028-024-00761-x.

DOI:10.1186/s13028-024-00761-x
PMID:39148122
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11325609/
Abstract

BACKGROUND

The Nova Scotia Duck Tolling Retriever (NSDTR) has previously been highlighted as a breed at risk for developing immune mediated diseases and cancer. The immune response is of great importance for the development of neoplastic disease and a dysregulated immune response may predispose to cancer. Two of the commonly seen immune mediated diseases in NSDTRs are immune mediated rheumatic disease (IMRD), which bears similarities to systemic lupus erythematosus (SLE) affecting humans, and steroid-responsive meningitis-arteritis (SRMA), which is a non-infectious inflammation of the meninges and the leptomeningeal vessels. The aim of this survey study was to investigate the lifetime prevalence of immune mediated diseases and tumors among Swedish NSDTRs based on owners' information. The study design was cross-sectional. A questionnaire was sent to 4102 persons who owned or had previously owned a NSDTR. The questions concerned information about the dog and its overall health status as well as specific diseases.

RESULTS

The response rate was 30%, including 935 live NSDTRs, corresponding to approximately 20% of the current population registered in Sweden (n = 4564), and 177 dead dogs. The surveyed dogs were spread over different ages and sex and corresponded to the typical demographic profile of the general dog population. Of the 935 individuals that were alive, 28 dogs (3%) were reported as previously diagnosed with IMRD and 33 dogs (3.5%) were reported as previously diagnosed with SRMA, one dog was reported to have been diagnosed with both SRMA and IMRD. There were 129 dogs (14%) reported to have or have had a neoplasia of some kind. For the dead dogs (n = 177), almost 40% of the owners reported neoplasia as the main reason for death/euthanasia.

CONCLUSION

This study reports an estimated lifetime prevalence of IMRD and SRMA, in the studied population of Swedish NSDTRs, of 3.0 and 3.5% respectively. In this study, 14% of the living dogs (n = 935) were reported to have a neoplasia of some kind and almost 40% of the deceased dogs (n = 177) were euthanized due to neoplasia or suspicion of it.

摘要

背景

新斯科舍诱鸭寻回猎犬(NSDTR)曾被认为是一种容易患免疫介导性疾病和癌症的品种。免疫反应对于肿瘤的发生非常重要,而失调的免疫反应可能会导致癌症。NSDTR 中常见的两种免疫介导性疾病是免疫介导性风湿病(IMRD),它与人类的系统性红斑狼疮(SLE)相似,以及类固醇反应性脑膜炎-动脉炎(SRMA),这是脑膜和软脑膜血管的非传染性炎症。本研究旨在基于主人的信息,调查瑞典 NSDTR 一生中免疫介导性疾病和肿瘤的患病率。该研究设计为横断面研究。向 4102 名拥有或曾经拥有 NSDTR 的人发送了一份问卷。问题涉及有关狗及其整体健康状况以及特定疾病的信息。

结果

回复率为 30%,包括 935 只活 NSDTR,相当于瑞典当前登记的 NSDTR 总数(n=4564)的 20%,以及 177 只死狗。调查犬分布在不同的年龄和性别,与一般犬群的典型人口统计学特征相对应。在 935 只活的个体中,有 28 只(3%)被报告以前患有 IMRD,33 只(3.5%)被报告以前患有 SRMA,1 只狗被报告同时患有 SRMA 和 IMRD。有 129 只(14%)狗被报告患有某种肿瘤。对于死亡犬(n=177),近 40%的主人报告肿瘤是死亡/安乐死的主要原因。

结论

本研究报告了在研究的瑞典 NSDTR 群体中,IMRD 和 SRMA 的终生患病率估计分别为 3.0%和 3.5%。在本研究中,报告有 14%的活狗(n=935)患有某种肿瘤,近 40%的死亡狗(n=177)因肿瘤或怀疑肿瘤而被安乐死。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515f/11325609/7b36425469b1/13028_2024_761_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515f/11325609/7b36425469b1/13028_2024_761_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/515f/11325609/7b36425469b1/13028_2024_761_Figa_HTML.jpg

相似文献

1
In sickness and health - a questionnaire based study regarding immune mediated diseases and neoplasia in Swedish Nova Scotia Duck Tolling Retrievers.健康与疾病:一项基于问卷调查的研究,调查瑞典诺威克纳维亚猎犬的免疫介导性疾病和肿瘤
Acta Vet Scand. 2024 Aug 15;66(1):39. doi: 10.1186/s13028-024-00761-x.
2
Disease patterns and incidence of immune-mediated disease in insured Swedish Nova Scotia Duck Tolling Retrievers.瑞典投保的新斯科舍诱鸭寻回犬免疫介导疾病的疾病模式和发病率。
Vet Rec. 2015 Jul 18;177(3):74. doi: 10.1136/vr.102960. Epub 2015 Jun 18.
3
Serum C-reactive protein concentrations in Nova Scotia Duck Tolling Retrievers with immune-mediated rheumatic disease.患有免疫介导性风湿病的新斯科舍诱鸭寻回犬的血清C反应蛋白浓度
Acta Vet Scand. 2017 Apr 17;59(1):21. doi: 10.1186/s13028-017-0289-9.
4
Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma.新斯科舍猎鸭寻回犬自身免疫性疾病和淋巴瘤患者中 IL-12/IL-23p40 水平升高。
Sci Rep. 2024 May 21;14(1):11624. doi: 10.1038/s41598-024-62265-y.
5
MHC class II polymorphism is associated with a canine SLE-related disease complex.主要组织相容性复合体II类多态性与犬类系统性红斑狼疮相关疾病复合体有关。
Immunogenetics. 2009 Aug;61(8):557-64. doi: 10.1007/s00251-009-0387-6. Epub 2009 Jul 28.
6
[Autoimmune diseases in dogs and their impact for breeding programs with special reference of the Nova Scotia Duck Tolling Retriever].[犬类自身免疫性疾病及其对繁殖计划的影响,特别提及新斯科舍诱鸭寻回犬]
Schweiz Arch Tierheilkd. 2018 Dec;160(12):711-717. doi: 10.17236/sat00186.
7
Clinical features and heritability of hypoadrenocorticism in Nova Scotia Duck Tolling Retrievers: 25 cases (1994-2006).新斯科舍诱鸭寻回犬肾上腺皮质功能减退症的临床特征与遗传力:25例病例(1994 - 2006年)
J Am Vet Med Assoc. 2007 Aug 1;231(3):407-12. doi: 10.2460/javma.231.3.407.
8
Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex.全基因组关联作图鉴定出多个犬类系统性红斑狼疮相关疾病复合性状的位点。
Nat Genet. 2010 Mar;42(3):250-4. doi: 10.1038/ng.525. Epub 2010 Jan 31.
9
Association of a dog leukocyte antigen class II haplotype with hypoadrenocorticism in Nova Scotia Duck Tolling Retrievers.犬白细胞抗原II类单倍型与新斯科舍诱鸭寻回犬肾上腺皮质功能减退症的关联
Tissue Antigens. 2010 Jun;75(6):684-90. doi: 10.1111/j.1399-0039.2010.01440.x. Epub 2010 Jan 28.
10
Examination of candidate genes for hypoadrenocorticism in Nova Scotia Duck Tolling Retrievers.对新斯科舍猎鸭寻回犬低肾上腺皮质功能减退候选基因的检查。
Vet J. 2011 Feb;187(2):212-6. doi: 10.1016/j.tvjl.2009.10.012.

本文引用的文献

1
Advances in SLE classification criteria.SLE 分类标准的进展。
J Autoimmun. 2022 Oct;132:102845. doi: 10.1016/j.jaut.2022.102845. Epub 2022 Jun 17.
2
ANA as an entry criterion for the classification of SLE.抗核抗体作为 SLE 分类的纳入标准。
Autoimmun Rev. 2019 Dec;18(12):102400. doi: 10.1016/j.autrev.2019.102400. Epub 2019 Oct 19.
3
The immune system and cancer evasion strategies: therapeutic concepts.免疫系统与癌症逃避策略:治疗概念。
J Intern Med. 2016 Jun;279(6):541-62. doi: 10.1111/joim.12470. Epub 2016 Jan 8.
4
Relapses in dogs with steroid-responsive meningitis-arteritis.患有类固醇反应性脑膜炎-动脉炎的犬类复发情况。
J Small Anim Pract. 2016 Feb;57(2):91-5. doi: 10.1111/jsap.12418. Epub 2015 Nov 19.
5
Disease patterns and incidence of immune-mediated disease in insured Swedish Nova Scotia Duck Tolling Retrievers.瑞典投保的新斯科舍诱鸭寻回犬免疫介导疾病的疾病模式和发病率。
Vet Rec. 2015 Jul 18;177(3):74. doi: 10.1136/vr.102960. Epub 2015 Jun 18.
6
Steroid-responsive meningitis-arteritis in Nova Scotia duck tolling retrievers.新斯科舍诱鸭寻回犬的类固醇反应性脑膜炎-动脉炎
Vet Rec. 2013 Nov 30;173(21):527. doi: 10.1136/vr.101847. Epub 2013 Oct 15.
7
Breed-predispositions to cancer in pedigree dogs.纯种犬患癌的品种易感性。
ISRN Vet Sci. 2013 Jan 17;2013:941275. doi: 10.1155/2013/941275. Print 2013.
8
Canine immune-mediated polyarthritis: part 2: diagnosis and treatment.犬免疫介导性多关节炎:第2部分:诊断与治疗
J Am Anim Hosp Assoc. 2012 Mar-Apr;48(2):71-82. doi: 10.5326/JAAHA-MS-5756. Epub 2012 Jan 19.
9
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
10
Mortality in north american dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death.1984 年至 2004 年北美犬只死亡率:对年龄、体型和品种相关死亡原因的调查。
J Vet Intern Med. 2011 Mar-Apr;25(2):187-98. doi: 10.1111/j.1939-1676.2011.0695.x. Epub 2011 Feb 25.